Dmitry Balyasny’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-12,667
Closed -$10.8M – 1630
2018
Q3
$10.8M Buy
+12,667
New +$10.8M 0.05% 465
2018
Q2
– Sell
-2,620
Closed -$4.18M – 2031
2018
Q1
$4.18M Buy
+2,620
New +$3.38M 0.02% 764

Other funds holding NKTR

Dmitry Balyasny's NKTR Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 154,245 shares worth $9.34M. The stake represents 0.01% of the portfolio and ranks #1116 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in NKTR as recently as Q1 2026.

Dmitry Balyasny first reported a position in NKTR in Q2 2015 and has held it in 27 quarters since. The position peaked at $19M in Q3 2017. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Dmitry Balyasny held 154,245 shares of Nektar Therapeutics worth $9.34M as of Q3 2026.
  • Nektar Therapeutics was a new Dmitry Balyasny position in Q3 2026.
  • Nektar Therapeutics made up 0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1116 holding.
  • Dmitry Balyasny first reported a position in Nektar Therapeutics in Q2 2015 and has held it in 27 quarters since.
  • Dmitry Balyasny's Nektar Therapeutics position peaked at $19M in Q3 2017.
  • 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.